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We describe a patient with nonischemic cardiomyopathy who underwent radiofrequency
(RF) catheter ablation for a drug-refractory ventricular tachycardia (VT). RF ablation from a
left ventricular (LV) endocardial site failed to eliminate the VT. Using a conventional ablation
catheter with the temperature-controlled mode, RF ablation from the LV epicardium resulted
in failed ablation because of low power due to a temperature limitation function. However, by
using a pericardial pigtail catheter for manual infusion and removal of saline within the
pericardial space, adequate energy could be delivered, and the ablation overlying the low-
voltage area successfully eliminated the VT.
(J Arrhythmia 2009; 25: 101–106)
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Introduction
Failure to ablate ventricular tachycardias (VTs)
from the endocardium of the left ventricle (LV) may
require an epicardial ablation.1–4) However, using a
conventional ablation catheter with the temperature-
controlled mode, radiofrequency (RF) catheter abla-
tion from the LV epicardium may result in failed
ablation because of low power due to a temperature
limitation function.
We describe here a case of hemodynamically
unstable VT. After a failed ablation from the
endocardial LV, we attempted to eliminate the VT
from an epicardial site. High-resolution substrate
mapping and an epicardial ablation using a conven-
tional ablation catheter under manual controlled
external irrigation were feasible and safe to cure the
VT.
Case Report
A 57-year-old man with nonischemic cardiomy-
opathy suﬀered from multiple appropriate shocks
from an implantable cardioverter-deﬁbrillator (ICD).
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Case Report
An echocardiogram demonstrated thinning and aki-
nesis of the left ventricular apex, with an overall LV
ejection fraction of 25%. During the clinical ar-
rhythmia, the surface ECG always revealed sus-
tained, monomorphic VT with an rS pattern in lead
V1, QS pattern in leads V2-5, a north-west axis, and
cycle length of 470msec. Using an endocardial
approach with an electroanatomical mapping system
(CARTO, Biosense Webster, Inc., CA, USA), he
underwent a ﬁrst session of RF catheter ablation for
this tachycardia. The interval from the earliest
ventricular activation to the earliest fast deﬂection
in any of the precordial leads was 59ms (pseudo-
delta),1) suggesting an epicardial source of the
VT.1–3,5) The VT was hemodynamically unstable
and required external cardioversion. No low-voltage
area was found in the LV endocardium from the
endocardial LV voltage map. During the clinical VT,
a focal pattern of activation was documented on the
activation map, arising near the LV apex, with
endocardial activation representing 43% of the VT
cycle length (Figure 1A). No endocardial signals
preceding the onset of the QRS complex during the
VT were found in the LV endocardium, and an
excellent pace map could not be obtained from the
LV endocardium. Seven ablation lesions were
delivered at that site using a 7-Fr 4mm-tip catheter
(NaviStar, Biosense Webster), but had no eﬀect on
the VT.
Because an epicardial source of the VT was
suspected from the results of the ﬁrst RF ablation
procedure, and because symptomatic electrical
storms and appropriate ICD shocks (more than 50
shocks/week) could not be controlled despite max-
imal pharmacologic therapy, we decided to perform
a second ablation procedure using epicardial map-
ping through a pericardial access.
Epicardial Mapping and Ablation
After informed written consent was obtained, a
second session of RF ablation was performed.
Intravenous heparin was discontinued 4 hours prior
to the procedure. General anesthesia was adminis-
tered, and continuous arterial blood pressure mon-
itoring was performed throughout the procedure.
Standard 5-Fr quadripolar catheters were placed in
the His bundle region and right ventricular apex
through a femoral venous access. During the electro-
physiologic study, the clinical VT was easily
induced with a single extrastimulus from the right
ventricular apex (Figure 1B).
Epicardial mapping was then performed using a
percutaneous transcardial approach as reported pre-
viously.4) Brieﬂy, the epicardial ablation utilized a
subxiphoid approach with an epidural needle using a
10mL syringe with contrast media, with the needle
advanced toward the left scapula guided by ﬂuoro-
scopy. When the pericardial space was thought to be
reached, a small bolus of 	1mL of contrast agent
was injected. When the tip was inside the pericardial
space, the cardiac silhouette was drawn. Two soft,
ﬂoppy-tipped guidewires were then introduced into
the pericardial space from a single epidural needle.
A 7 Fr sheath used for standard ablation was then
advanced over the guidewire. A 4-mm-tip ablation
catheter (NaviStar, Biosense Webster) was intro-
duced through the sheath into the pericardial sac.
The exposed epicardial surface was mapped during
sinus rhythm using ﬂuoroscopy and an electroana-
tomic mapping system (Biosense Webster). The scar
area was deﬁned as an area having an amplitude of
	0:1mV without capture by local bipolar stimula-
tion at the maximum output with 10V and a 2-ms
pulse width. A non-arrhythmogenic area and low-
voltage area were also deﬁned as an area having
an amplitude of >0:6mV and >0:1 to 	0:6mV,
respectively.6,7)
A detailed voltage map disclosed an extensive
region of injured myocardium near the LV apex of
the left ventricle (Figure 1C). No electrically unex-
citable scar was found in the epicardium before
the RF energy applications. Based on our recently
reported strategy,6) pace mapping was performed
within the low-voltage area to delineate the complete
VT re-entry circuit. As shown in Figures 1B and 1C,
we found a site where the paced QRS morphology
was similar to the clinical VT morphology; however,
pace mapping could not be performed completely
because of repetitively occurring hemodynamically
unstable VT. Therefore, RF energy was delivered at
the site which yielded an excellent pace map and the
sites with discrete late-systolic potentials within the
low-voltage area. To abolish not only the clinical VT
isthmus but also all possible isthmuses, a linear
ablation was created from the anterior-to-posterior
aspect. Prior to the ablation, a standard coronary
angiogram was performed in order to avoid deliver-
ing RF energy near the epicardial coronary arteries.
Absence of diaphragmatic pacing was also con-
ﬁrmed at the ablation sites prior to the RF energy
deliveries.
The endpoint of the RF delivery was the elimi-
nation or signiﬁcant reduction in the targeted late
potentials (Figure 2B) and the loss of bipolar pacing
capture immediately after the RF energy delivery. A
total of 27 deliveries of RF energy were performed
using a maximum power of 40 watts and a maximum
electrode-tissue interface temperature of 60 C.
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However, insuﬃcient cooling to the catheter by the
local blood ﬂow in the pericardial space resulted in a
low delivered power of less than 5W because of the
temperature limitation and, then, no creation of a
suﬃciently large and deep lesion resulted. The local
impedance also did not vary during those RF
deliveries. To resolve this problem, we decided to
attempt the ablation with a manually controlled
external irrigation. A 5-Fr pigtail catheter was placed
deep within the pericardial space through another
sheath (Figure 2A). The manually controlled ﬂow rate
of the saline (20 C) was about 20mL/min during
the RF energy delivery based on a previous report.8)
The injected saline solution was evacuated manually
using the same pigtail catheter repeatedly after
several RF applications. Continuous arterial blood
monitoring revealed that the hemodynamic status
was stable during the irrigation. RF energy was
delivered in a power-control mode at 15–20W for
30–60 seconds. The catheter temperature ranged
from 35 C to 42 C. The local impedance decreased
from 101 20 to 89 18 after the RF delivery.
By using a pigtail catheter for the infusion and
removal of the saline, we were able to deliver the RF
energy with no occurrence of cardiac tamponade,
and a cluster of RF lesions crossing the apical low-
voltage area from the anterior-to-posterior aspect
was created (Figure 1C). The targeted VT was no
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Figure 1 A. Voltage map (upper panel) and activation map (lower panel) of the endocardial surface of the left ventricle (LV)
viewed from the left anterior oblique aspect.
The voltage map disclosed preserved amplitude of the bipolar electrograms throughout the LV endocardium, indicating no low-voltage
area in the LV. A voltage-graded color scale is shown on the right side, ranging from 	0:1mV (red) to 0:6mV (purple). The activation
map (bottom panel) during the ventricular tachycardia (VT) showed a centrifugal activation pattern, arising from near the LV apex. An
activation-graded color scale is shown on the right side, ranging from 209msec (red) to 8msec (purple).
B. Twelve-lead ECG: clinical VT (left) and pace mapping (right).
C. The voltage map of the epicardial surface of the LV viewed from the left anterior oblique aspect.
Low-amplitude regions were found from the LV anterior wall to the apex. The low-voltage area (90 cm2) occupied 17.4% of the entire LV
epicardial surface. The asterisk (*) indicates the site where an excellent pace map was obtained. A cluster ablation lesion across the apical
low-voltage area from the anterior-to-posterior aspect was created. The blue and brown tags represent the ablation sites with or without
external irrigation, respectively.
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longer inducible after the completion of serial point
ablations, but non-clinical hemodynamically unsta-
ble fast VT (with a left bundle branch block
conﬁguration, left axis deviation, and cycle length
of 280msec) requiring a commanded shock through
the device was induced only with up to triple
extrastimuli. The catheters were removed from the
pericardial space, and the subxiphoid sheath was
removed the next day.
Postoperatively, the patient experienced self-lim-
ited pleuropericarditic chest pain consistent with
mild pericarditis. Echocardiography performed the
following day demonstrated no signiﬁcant pericardial
ﬂuid accumulation. No other complications occurred
during or after the ablation procedure, and the patient
was discharged with 200mg/day of oral amiodarone.
The patient has done well with no recurrence of VT
during a 15-month follow-up period.
Discussion
Our case report demonstrated that (1) a manual
controlled saline irrigation in the pericardial space
was a feasible and eﬀective strategy for epicardial
RF ablation in temperature-limiting situations, and
that (2) strict voltage criteria based on electro-
anatomical mapping was feasible for clarifying the
epicardial arrhythmogenic areas in nonischemic
cardiomyopathy.
Sustained monomorphic VT associated with struc-
tural heart disease is often associated with areas of
ventricular scar comprised of surviving myocytes
and ﬁbrotic tissue. However, in our case, the low-
voltage area was not found in the endocardial LV but
was found in the LV epicardium. In patients with
ischemic cardiomyopathy, the scar is found more
often in the LV endocardium than in the LV
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Figure 2 A. Radiographs obtained in the right anterior oblique (RAO, 35; left panel) and left anterior oblique (LAO, 45; right
panel) projections showing the ablation catheter (Ablation) and a pigtail catheter (Pigtail) used for infusion and suction of the
saline in the epicardial space.
An implanted atrial lead in the right atrial appendage (RAA) and right ventricular deﬁbrillation lead (RV ICD lead) also are seen.
B. Examples of local electrograms recorded at the left ventricular epicardium before (left panel) and after (right panel) the
ablation.
The discrete late systolic potentials (arrows) disappeared after a radiofrequency energy delivery for 60 seconds. Pacing at high output no
longer captured the myocardium after the ablation at these sites.
J Arrhythmia Vol 25 No 2 2009
104
epicardium. A recent study demonstrated that it was
nearly three times greater in the endocardium
compared with the epicardium.9) However, in non-
ischemic cardiomyopathy as in our case, no scar
tissue is sometimes detected in the LV endocardium,
and often a markedly large low-amplitude region is
seen in the LV epicardium. A recent study with 22
consecutive patients with nonischemic cardiomyop-
athy and reentrant VT demonstrated that 46% of the
endocardial ablations were unsuccessful, and that
additional epicardial delivery of RF energy was
required for a cure in 6 (86%) of 7 patients with a
successful ablation.4) Our case and previous studies
indicate that when no scar area and/or suitable
ablation sites are found on the endocardial mapping
in patients with nonischemic cardiomyopathy, epi-
cardial mapping and ablation should be considered.
Because the scar-related, macro-reentrant VTs
in patients with structural heart disease are often
hemodynamically unstable, it is diﬃcult to clarify
the VT circuit by mapping during the VT. In our
case, by adopting the elaborate voltage criteria for
determining the low-voltage area,6,7) and using
endocardial and epicardial electroanatomic mapping
during sinus rhythm, we could deﬁne the detailed
distribution of the low-voltage area tissue in the LV
with no potential complications. The targeted ar-
rhythmogenic area (	0:6mV) for the RF energy
deliveries was restricted approximately to half the
size of the generally targeted area with an amplitude
of 	1:5mV.6) Indeed, in this case the voltage
mapping with the generally adopted criteria (a low-
voltage area: 	1:5mV) represented an area twice the
size of the targeted arrhythmogenic area. The
abnormal regions were easily delineated and made
lucid during the procedure with the elaborate voltage
criteria. After the deliveries of the RF energy at the
low-voltage area, the clinical VT no longer occurred
during a relatively long-term follow-up period.
Therefore, we think that a high-resolution substrate
mapping-guided RF ablation is very useful in
patients with hemodynamically unstable, post-in-
farction VTs or frequent appropriate ICD shocks.6,7)
A recent technical paper showed that precordial
distress was observed in up to 29% of patients and in
all of them it could be controlled with the regular
administration of anti-inﬂammatory medications
after an epicardial catheter ablation.2) In a porcine
model of ablation-related pericarditis, intrapericar-
dial instillation of intermediate-acting corticoste-
roids eﬀectively prevented any inﬂammatory adhe-
sion formation after epicardial ablation.10)
Fortunately in our case, only self-limited chest pain
continued for several days. However, that symptom
and a slight pericardial eﬀusion disappeared com-
pletely by the day of discharge without the use of
any anti-inﬂammatory agents.
Epicardial ablation for VT could be successfully
performed with a conventional non-irrigated catheter
in some patients.4) However, in our case, adequate
RF energy delivery could not be obtained with a
conventional catheter because of a temperature
limiting function. In such a clinical setting, the use
of an irrigated catheter or cryoablation catheter may
be useful and safe. However, an external irrigation is
relatively contraindicated in the closed pericardial
space because of the potential for pericardial
tamponade. Recently, one case report describe a
successful procedure using an automatic externally
irrigated epicardial ablation with a subxiphoid
surgical approach.8) Based on that report, we
attempted to perform a manually-controlled external
irrigation. By using a pericardial pigtail catheter for
infusion and removal of the saline, the RF energy
could be delivered repeatedly with adequate power.
Finally, the clinical VT arising from the LV
epicardium could be eliminated with no potential
complications in the heart or other organs. We
believe that our ablation method using a conven-
tional ablation catheter under a manual controlled
external irrigation is feasible and safe for curing
epicardial tachyarrhythmias.
Conclusions
With saline infusion and removing the irrigation
ﬂuid from the pericardial space with a percutaneous
subxyphoid access, a manually-controlled external
irrigation technique is a safe and eﬀective strategy
for epicardial ablation. An endocardial and epicar-
dial high-resolution substrate mapping based on
strict voltage criteria may be useful for elucidating
epicardial arrhythmogenic areas in nonischemic
cardiomyopathy.
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